Patents by Inventor Alejandro Ibañez Costa

Alejandro Ibañez Costa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GHRELIN O-ACYLTRANSFERASE (GOAT) AND USES THEREOF
    Publication number: 20200158732
    Abstract: The present invention relates to the use of levels of the amount or concentration of the ghrelin-O-acyltransferase (GOAT) enzyme or of the mRNA encoding this protein, obtained ex vivo from a biological sample isolated from a subject, as an efficient tool for obtaining data that can be used in the clinical diagnosis of prostate cancer.
    Type: Application
    Filed: November 28, 2016
    Publication date: May 21, 2020
    Inventors: Justo P. CASTAÑO FUENTES, Raúl M. LUQUE HUERTAS, Manuel D. GAHETE ORTIZ, Daniel HORMAECHEA AGULLA, María José REQUENA TAPIA, Enrique GÓMEZ GÓMEZ, Julia CARRASCO VALIENTE, Alejandro IBÁÑEZ COSTA, María del Mar MORENO, José VALERO ROSA
  • USE OF IN1-GHRELIN FOR THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20190331684
    Abstract: The present invention relates to a diagnostic and/or prognostic method for the diagnosis and/or prognosis of cancer in a patient. Particularly, the present invention relates to diagnostic and/or prognostic methods for the diagnosis and/or prognosis of cancer which comprise quantifying the expression levels of In1-ghrelin in a plasma sample isolated from an individual; comparing the obtained levels with the expression levels of In1-ghrelin in a reference sample; and assigning the patients having expression levels of In1-ghrelin that are greater than and statistically significant with respect to the levels of the reference sample to the group of individuals at risk of having cancer. The present invention also provides a diagnostic method for the diagnosis of bladder and/or colon cancer which comprises quantifying the expression levels of In1-ghrelin, GOAT and/or GHS-R1b in tissue samples. The present invention also relates to an siRNA useful in a cancer treatment method.
    Type: Application
    Filed: December 4, 2017
    Publication date: October 31, 2019
    Inventors: Raúl M. Luque Huertas, Justo P. Castaño Fuentes, Manuel D. Gahete Ortiz, Alejandro Ibañez Costa, Daniel Hormaechea Agulla, Juan Manuel Jimeñez Vacas, André Moráis Sarmento Borges Cabral, Fernando López López, Maria José Requena Tapia, Enrique Gómez Gómez, Julia Carrasco Valiente